China’s aggressive campaign to bring down drug prices is leading to a “vicious cycle” and will prevent the emergence of a national pharmaceutical champion, said one of the country’s biggest drug makers. In some of the strongest criticism yet over a new policy that is likely to save China tens of billions of dollars, but